Joshua Barnes

Joshua is a clinical research specialist who has 8 years of experience in managing and executing Oncology trials. Cumulatively, he has coordinated over 50 research projects across all cancer groups, from Phase 1 through to Phase IV and particularly with immunotherapies, small-molecule targeted therapies and combination chemotherapy.

Josh’s background in pharmaceutical medicine places him in a unique position to understand the mechanism of action behind the novel EDV cyto-immunotherapy and to execute EDV-based clinical trials to their best advantage.